(Q59312520)
Statements
CA-125 response patterns in patients with recurrent ovarian cancer treated with pegylated liposomal doxorubicin (PLD) (English)
Ana Oaknin
Pilar Barretina
Xavier Pérez
Laura Jimenez
Montserrat Velasco
Maria Alsina
Josep Ramon Germà